von Hippel–Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement
- 28 September 2022
- Vol. 128 (22), 4027-4028
- https://doi.org/10.1002/cncr.34460
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Multidisciplinary integrated care pathway for von Hippel–Lindau diseaseCancer, 2022
- Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau DiseaseThe New England Journal of Medicine, 2021
- Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational studyEuropean Journal of Surgical Oncology, 2021
- Von Hippel-Lindau disease: an evaluation of natural history and functional disabilityNeuro-Oncology, 2016
- First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel–Lindau (VHL) disease: clinical outcome and patterns of radiological responseFamilial Cancer, 2014